Digital Single-operator Cholangioscopy (DSOC) Improves Interobserver Agreement (IOA) and Accuracy for Evaluation of Indeterminate Biliary Strictures: The Monaco Classification.


Journal

Journal of clinical gastroenterology
ISSN: 1539-2031
Titre abrégé: J Clin Gastroenterol
Pays: United States
ID NLM: 7910017

Informations de publication

Date de publication:
01 02 2022
Historique:
received: 15 07 2019
accepted: 03 01 2020
pubmed: 11 2 2020
medline: 11 3 2022
entrez: 11 2 2020
Statut: ppublish

Résumé

Visual characteristics seen during digital single-operator cholangioscopy (DSOC) have not been validated. The aim of this 2-phase study was to define terminology by consensus for the visual diagnosis of biliary lesions to develop a model for optimization of the diagnostic performance of DSOC. In phase 1 (criteria identification), video-cholangioscopy clips were reviewed by 12 expert biliary endoscopists, who were blinded to the final diagnosis. Visual criteria were consolidated into the following categories: (1) stricture, (2) lesion, (3) mucosal features, (4) papillary projections, (5) ulceration, (6) abnormal vessels, (7) scarring, (8) pronounced pit pattern.During the second phase (validation), 14 expert endoscopists reviewed DSOC (SpyGlass DS, Boston Scientific) clips using the 8 criteria to assess interobserver agreement (IOA) rate. In phase 1, consensus for visual findings were categorized into 8 criteria titled the "Monaco Classification." The frequency of criteria were: (1) presence of stricture-75%, (2) presence of lesion type-55%, (3) mucosal features-55%, (4) papillary projections-45%, (5) ulceration-42.5%, (6) abnormal vessels-10%, (7) scarring-40%, and (8) pronounced pit pattern-10%. The accuracy on final diagnosis based on visual impression alone was 70%.In phase 2, the IOA rate using Monaco Classification criteria ranged from slight to fair. The presumptive diagnosis IOA was fair (κ=0.31, SE=0.02), and overall diagnostic accuracy was 70%. The Monaco classification identifies 8 visual criteria for biliary lesions on single-operator digital cholangioscopy. Using the criteria, the IOA and diagnostic accuracy rate of DSOC is improved compared with prior studies.

Sections du résumé

BACKGROUND
Visual characteristics seen during digital single-operator cholangioscopy (DSOC) have not been validated. The aim of this 2-phase study was to define terminology by consensus for the visual diagnosis of biliary lesions to develop a model for optimization of the diagnostic performance of DSOC.
MATERIALS AND METHODS
In phase 1 (criteria identification), video-cholangioscopy clips were reviewed by 12 expert biliary endoscopists, who were blinded to the final diagnosis. Visual criteria were consolidated into the following categories: (1) stricture, (2) lesion, (3) mucosal features, (4) papillary projections, (5) ulceration, (6) abnormal vessels, (7) scarring, (8) pronounced pit pattern.During the second phase (validation), 14 expert endoscopists reviewed DSOC (SpyGlass DS, Boston Scientific) clips using the 8 criteria to assess interobserver agreement (IOA) rate.
RESULTS
In phase 1, consensus for visual findings were categorized into 8 criteria titled the "Monaco Classification." The frequency of criteria were: (1) presence of stricture-75%, (2) presence of lesion type-55%, (3) mucosal features-55%, (4) papillary projections-45%, (5) ulceration-42.5%, (6) abnormal vessels-10%, (7) scarring-40%, and (8) pronounced pit pattern-10%. The accuracy on final diagnosis based on visual impression alone was 70%.In phase 2, the IOA rate using Monaco Classification criteria ranged from slight to fair. The presumptive diagnosis IOA was fair (κ=0.31, SE=0.02), and overall diagnostic accuracy was 70%.
CONCLUSIONS
The Monaco classification identifies 8 visual criteria for biliary lesions on single-operator digital cholangioscopy. Using the criteria, the IOA and diagnostic accuracy rate of DSOC is improved compared with prior studies.

Identifiants

pubmed: 32040050
pii: 00004836-202202000-00003
doi: 10.1097/MCG.0000000000001321
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

e94-e97

Informations de copyright

Copyright © 2020 Wolters Kluwer Health, Inc. All rights reserved.

Références

Chin MW, Byrne MF. Update of cholangioscopy and biliary strictures. World J Gastroenterol. 2011;17:3864–3869.
Moon JH, Terheggen G, Choi HJ, et al. Peroral cholangioscopy: diagnostic and therapeutic applications. Gastroenterology. 2013;144:276–282.
Terheggen G, Neuhaus H. New options of cholangioscopy. Gastroenterol Clin North Am. 2010;39:827–844.
Parsi MA. Peroral cholangioscopy in the new millennium. World J Gastroenterol. 2011;17:1–6.
Chen YK, Parsi MA, Binmoeller KF, et al. Single-operator cholangioscopy in patients requiring evaluation of bile duct disease or therapy of biliary stones (with videos). Gastrointest Endosc. 2011;74:805–814.
Sethi A, Widmer J, Shah NL, et al. Interobserver agreement for evaluation of imaging with single operator choledochoscopy: what are we looking at? Dig Liver Dis. 2014;46:518–522.
Nguyen NQ, Binmoeller KF, Shah JN. Cholangioscopy and pancreatoscopy (with videos). Gastrointest Endosc. 2009;70:1200–1210.
Chen YK, Pleskow DK. SpyGlass single-operator peroral cholangiopancreatoscopy system for the diagnosis and therapy of bile-duct disorders: a clinical feasibility study (with video). Gastrointest Endosc. 2007;65:832–841.
Draganov PV, Chauhan S, Wagh MS, et al. Diagnostic accuracy of conventional and cholangioscopy-guided sampling of indeterminate biliary lesions at the time of ERCP: a prospective, long-term follow-up study. Gastrointest Endosc. 2012;75:347–353.
Fukuda Y, Tsuyuguchi T, Sakai Y, et al. Diagnostic utility of peroral cholangioscopy for various bile-duct lesions. Gastrointest Endosc. 2005;62:374–382.
Woo YS, Lee JK, Oh SH, et al. Role of SpyGlass peroral cholangioscopy in the evaluation of indeterminate biliary lesions. Dig Dis Sci. 2014;59:2565–2570.
Ramchandani M, Reddy DN, Gupta R, et al. Role of single-operator peroral cholangioscopy in the diagnosis of indeterminate biliary lesions: a single-center, prospective study. Gastrointest Endosc. 2011;74:511–519.
Sethi A, Doukides T, Sejpal DV, et al. Interobserver agreement for single operator choledochoscopy imaging: can we do better? Diagn Ther Endosc. 2014;2014:730731.
Seo DW, Lee SK, Yoo KS, et al. Cholangioscopic findings in bile duct tumors. Gastrointest Endosc. 2000;52:630–634.
Kim HJ, Kim MH, Lee SK, et al. Tumor vessel: a valuable cholangioscopic clue of malignant biliary stricture. Gastrointest Endosc. 2000;52:635–638.
Robles-Medranda C, Valero M, Soria-Alcivar M, et al. Reliability and accuracy of a novel classification system using peroral cholangioscopy for the diagnosis of bile duct lesions. Endoscopy. 2018;50:1059–1070.

Auteurs

Amrita Sethi (A)

Columbia University Medical Center, New York City.

Amy Tyberg (A)

Department of Medicine, Rutgers Robert Wood Johnson Medical School, The State University of New Jersey, Robert Wood Johnson University Hospital, New Brunswick, NJ.

Adam Slivka (A)

University of Pittsburgh Medical Center, Pittsburgh, PA.

Douglas G Adler (DG)

University of Utah School of Medicine, Salt Lake City, UT.

Amit P Desai (AP)

Columbia University Medical Center, New York City.

Divyesh V Sejpal (DV)

North Shore-LIJ Health System, Manhattan.

Douglas K Pleskow (DK)

Beth Israel Deaconess Medical Center, Boston, MA.

Helga Bertani (H)

Nuovo Ospedale Civile S. Agostino Estense, Modena, Italy.

Seng-Ian Gan (SI)

Virginia Mason Medical Center, Seattle, WA.

Raj Shah (R)

University of Colorado, Denver, CO.

Urban Arnelo (U)

Karolinska Institutet, Solna, Sweden.

Paul R Tarnasky (PR)

Methodist Dallas Medical Center, Dallas.

Subhas Banerjee (S)

Veteran Affairs/Stanford University, Stanford, CA.

Takao Itoi (T)

Tokyo Medical University, Tokyo, Japan.

Jong Ho Moon (JH)

Soon Chun Hyang School of Medicine, Chungcheongnam-do, Republic of Korea.

Dong Choon Kim (DC)

Soon Chun Hyang School of Medicine, Chungcheongnam-do, Republic of Korea.

Monica Gaidhane (M)

Department of Medicine, Rutgers Robert Wood Johnson Medical School, The State University of New Jersey, Robert Wood Johnson University Hospital, New Brunswick, NJ.

Isaac Raijman (I)

Greater Houston Gastroenterology, Houston, TX.

Bret T Peterson (BT)

Mayo Clinic, Rochester, MN.

Frank G Gress (FG)

Mount Sinai Hospital, NY.

Michel Kahaleh (M)

Department of Medicine, Rutgers Robert Wood Johnson Medical School, The State University of New Jersey, Robert Wood Johnson University Hospital, New Brunswick, NJ.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH